Texas Invests $50 Million in Ibogaine Research for Addiction Treatment, Advocates Still Eye Tri-State
- Texas Governor Greg Abbott signed Senate Bill 2308 on Wednesday in Austin, allocating $50 million to study ibogaine as a medication.
- The bill establishes a partnership among academic institutions, medical centers, and pharmaceutical companies to carry out FDA-approved clinical studies on ibogaine for treating addiction and mental health disorders.
- Stanford Medicine's 2024 study showed ibogaine combined with magnesium safely reduces PTSD, anxiety, depression, and improves cognitive function in veterans with brain injuries.
- Bryan Hubbard, American Ibogaine Initiative director, said, "It has no recreational purpose whatsoever," and noted Indiana plans to start ibogaine research in January 2026.
- Texas’s investment positions it as a leader in psychedelic research and may prompt other states to fund addiction treatments using ibogaine.
21 Articles
21 Articles
Abbott signs groundbreaking psychedelic research bill to help bring ibogaine through clinical trials
The Texas governor signed a $50 million bill into law on Wednesday to help bring ibogaine through FDA-approved clinical trials for opioid use disorders and other neurological and mental health conditions. Advocates said the legislation is the largest state-funded psychedelic research initiative in history.
Texas Governor Signs Bill To Create Ibogaine Research Consortium, Aiming To Develop FDA-Approved Psychedelic Drug
Texas Gov. Greg Abbott (R) has signed into law a bill to create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions. The ultimate goal of the project is to develop the psychedelic into a prescription drug with U.S. Food and Drug Administration (FDA) approval, with the state retaining a portion of the profit. “Texas is now leading the way …
Texas to expand psychedelic research with $50M ibogaine investment
AUSTIN (KXAN) — Texas Gov. Greg Abbott signed legislation Tuesday that invests $50 million into clinical research of ibogaine -- a naturally occurring psychedelic substance that could treat post-traumatic stress disorder, opioid use disorder and other mental health conditions. For years, veterans and others suffering from PTSD have sought ibogaine treatment in Mexico, where the substance is not heavily regulated. In the United States, ibogaine i…
'Open to new knowledge': Rick Perry is back — and he's changed his mind on a major issue
As Texas sets to crack down on the recreational use of cannabis, state leaders are opting to invest $50 million in another plant with purported medicinal benefits – a psychedelic called ibogaine.For several years, people have silently traveled to clinics in Mexico to take ibogaine. The extract of an ancient African shrub has been used across the Texas border to alleviate addiction and brain trauma.Texas Gov. Greg Abbott is set to sign Senate Bil…
Coverage Details
Bias Distribution
- 71% of the sources are Center
To view factuality data please Upgrade to Premium